WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010149355) IMMUNOGLOBULIN PREPARATION FOR THE TREATMENT OF HIV-1 INFECTION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/149355    International Application No.:    PCT/EP2010/003779
Publication Date: 29.12.2010 International Filing Date: 24.06.2010
IPC:
C07K 16/42 (2006.01), C07K 1/22 (2006.01)
Applicants: WEZEN BIOPHARMACEUTICALS S.R.L. A SOCIO UNICO [IT/IT]; Via Machiavelli, 87/a I-09131 Cagliari (IT) (For All Designated States Except US).
METLAS, Radmila [RS/RS]; (RS) (For US Only).
V SRDIC-RAJIC, Tatjana [RS/RS]; (RS) (For US Only).
CONCAS, Daniela [IT/IT]; (IT) (For US Only)
Inventors: METLAS, Radmila; (RS).
V SRDIC-RAJIC, Tatjana; (RS).
CONCAS, Daniela; (IT)
Agent: BANFI, Paolo; Bianchetti Bracco Minoja S.r.l. Via Plinio, 63 I-20129 Milano (IT)
Priority Data:
12/492,617 26.06.2009 US
Title (EN) IMMUNOGLOBULIN PREPARATION FOR THE TREATMENT OF HIV-1 INFECTION
(FR) PRÉPARATION D'IMMUNOGLOBULINES POUR LE TRAITEMENT DE L'INFECTION PAR VIH-1
Abstract: front page image
(EN)An immunoglobulin (Ig) preparation containing polyclonal IgG-reactive antibodies (Abs), methods for preparing said preparation and pharmaceutical compositions containing it in admixture with suitable excipients, the use of said preparation or composition, alone or in combination with antiretroviral drugs, for the prophylaxis or treatment of HIV-1 infection.
(FR)La présente invention concerne la préparation d'immunoglobulines (Ig) contenant des anticorps polyclonaux anti-IgG (Abs), des procédés de préparation de ladite préparation et des compositions pharmaceutiques la contenant en mélange avec des excipients appropriés, l'utilisation de ladite préparation ou composition, seule ou en combinaison avec des médicaments antirétroviraux, pour la prophylaxie ou le traitement de l'infection par le VIH-1.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)